European Union announces new programme to improve Parkinson’s diagnosis

News

Author: Parkinson's Life editorsPublished: 17 January 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

PD-Podcast-DBS

The European Union has announced the launch of the Magnetic Diagnostic Assay for Neurodegenerative Diseases (MADIA) – a project with the ultimate goal of improving diagnosis for those living with Parkinson’s and Alzheimer’s.

The project, which is in partnership with a range of international universities and institutions, will focus on the development of a novel device that will help clinicians perform a simple click and analysis to diagnose both conditions.

Dr Francisco Campos, of the Clinical Neurosciences Research Laboratory, said: “An early diagnosis is crucial to maximise the effectiveness of the treatments in order to mitigate the devastating effects of these illnesses and slow disease progression.

“MADIA is funded by the European Union’s Horizon 2020 research and innovation programme, and consists of a multitasking team with more than 50 professionals in the fields of biology, physics and engineering.”

For comprehensive information about Parkinson’s diagnosis please visit the EPDA website.

Go Back

Share this story

Comments


Related articles


Audrey and Marc lead

Carers' Corner

“That you can be you – and still fight this beast everyday – makes you a giant”

How one carer and her husband overcame “terrifying” diagnosis

READ MORE
Tom Isaacs tribute lead

Perspectives

Tributes paid to “inspirational” Tom Isaacs

Social media users around the world react to death of Tom Isaacs

READ MORE
John McLean at work

Perspectives

‘Which Way Up’: documentary following painter John McLean

UK screening of film about painter with Parkinson’s, John McLean

READ MORE